A45 Radiokinetic therapy is a technique to treat cancer cells with photochemical function. If conventional photodynamic therapy is limited in the treatment of the epidermis, it is a new technology completely solved. This technique can be applied very effectively to the treatment of patients in stage 3 and 4 because there is no damage to normal human cells. 

A45 Tumor power therapy principle

Step 1: Tumor cells are wrapped with drugs.

It is injected with the catalyst before the treatment. The catalyst is released from the body after treatment through metabolism. The dosing drug will react positively to the tumor cells. Tumor cells are absorbed 10 to 20 times more than normal cells. This drug accumulates in the mitochondrial membrane of the tumor cells and acts as a target molecule of the molecule. 

Step 2: Conversion of energy to drug activation 

The optoelectronic accelerator is used to irradiate the photon beam to the patient's local or whole body. At this time, the photosensitizer reacts to the target molecule attached to the tumor cell. The photon charger only activates the sensitizer and does not kill direct cancer cells. In other words, the radiation dose used to activate the photosensitizer is only 1 in 10 minutes for conventional radiation therapy and does not affect the normal tissue cells of the human body. 

Step 3: The compound acts on cancer cells deeply. 

When a drug is activated on the surface of a cancer cell, a nuclear reaction occurs. In this case, the change in the molecular structure triggers a toxic compound. This compound penetrates cancer cells with nanoparticles and causes cancer cells to necrotize. 

Step 4: Irritation of the specificity of the whole body 

The necrosis of tumor cells exposes the antigen to the tumor, causing an immune response specific for the whole body. These immune responses react to metastatic tumors in other parts of the body and have a long-term therapeutic effect in suppressing recurrence. 

Theoretical basis of A45 treatment

The RDT treatment, represented by A45, is actually an upgraded version of Photodynamic Therapy (PDT). Photodynamic therapy is a new technology for treating diseases using photodynamic effects, the basis of which is the photodynamic effect. The process involves the irradiation of specific wavelengths of radiation to the tumor tissue, where the absorbed minerals are stimulated and the photosensitizer reacts with the surrounding oxygen energy to the tumor cells. It causes an oxidation reaction with the tumor cells and necroses with the tumor. Currently, photodynamic therapy is a universal treatment technology. 

It is a new treatment that precisely targets cancer cells to prevent normal tissue damage and stimulates body immunity.

HK HIS aims to provide more accurate and effective treatment opportunities through A45 treatment.